DEVELOPMENT OF THYROIDAL SUPPRESSION BY TRIIODOTHYRONINE DURING 6 MONTHS TREATMENT OF THYROTOXICOSIS WITH ANTITHYROID DRUGS

被引：38
|
作者：
ALEXANDER, WD
HARDEN, RM
SHIMMINS, J
MCLARTY, D
MCGILL, P
机构：
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 1967年 / 27卷 / 12期
关键词：
D O I：
10.1210/jcem-27-12-1682
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1682 / +
页数：1
相关论文
共 50 条
  • [21] TOTAL APLASTIC ANEMIA AND OTHER COMPLICATIONS FOLLOWING SO-CALLED ANTITHYROID DRUGS IN TREATMENT OF THYROTOXICOSIS
    RIENHOFF, WF
    SOUTHERN MEDICAL JOURNAL, 1961, 54 (09) : 1034 - &
  • [22] Therapeutic Plasma Exchange for the Treatment of Hyperthyroidism: Approach to the Patient with Thyrotoxicosis or Antithyroid-Drugs Induced Agranulocytosis
    Tizianel, Irene
    Sabbadin, Chiara
    Censi, Simona
    Clausi, Cristina
    Colpo, Anna
    Leahu, Anca Irina
    Iacobone, Maurizio
    Mian, Caterina
    Scaroni, Carla
    Ceccato, Filippo
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [23] THE INCIDENCE OF RECURRENCE AND HYPOTHYROIDISM FOLLOWING TREATMENT WITH ANTITHYROID DRUGS, SURGERY OR RADIOIODINE IN ALL PATIENTS WITH THYROTOXICOSIS IN MALMO DURING THE PERIOD 1970-1974
    BERGLUND, J
    CHRISTENSEN, SB
    DYMLING, JF
    HALLENGREN, B
    JOURNAL OF INTERNAL MEDICINE, 1991, 229 (05) : 435 - 442
  • [24] SUPPRESSIBILITY OF THYROID FUNCTION DURING TREATMENT WITH ANTITHYROID DRUGS IN GRAVES DISEASE
    WILS, JA
    KLOPPENBORG, PW
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 30 (03) : 406 - +
  • [25] DEVELOPMENT OF CUSHINGS DISEASE DURING 6 MONTHS TREATMENT WITH AN OVULATION INHIBITOR
    WINKLER, G
    BAHNER, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1967, 97 (50) : 1696 - &
  • [26] Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to graves disease - A novel side effect of antithyroid drugs
    Suzuki, S
    Ichikawa, K
    Nagai, M
    Mikoshiba, M
    Mori, J
    Kaneko, A
    Sekine, R
    Asanuma, N
    Hara, M
    Nishii, Y
    Yamauchi, K
    Aizawa, T
    Hashizume, K
    ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (06) : 693 - 696
  • [27] COMPARISON OF TRIIODOTHYRONINE SUPPRESSION TEST BY 20-MINUTE AND 24-HOUR THYROIDAL I-131 UPTAKE IN PATIENTS RECEIVING THIOAMIDE DRUGS
    NAGATAKI, S
    UCHIMURA, H
    MATSUZAKI, F
    MASUYAMA, Y
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (02) : 255 - 261
  • [28] INCREASED SERUM INTERLEUKIN-1-BETA DURING TREATMENT OF HYPERTHYROIDISM WITH ANTITHYROID DRUGS
    TSATSOULIS, A
    VLACHOYIANNOPOULOS, PG
    DALEKOS, GN
    JOHNSON, EO
    MOUTSOPOULOS, HM
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (09) : 654 - 658
  • [29] RECOVERY OF INITIALLY SUPPRESSED THYROIDAL RADIOIODINE UPTAKE DURING LONG-TERM ANTITHYROID TREATMENT OF EUTHYROID VOLUNTEERS AND HYPERTHYROID PATIENTS
    STUDER, H
    ROHNER, R
    KONIG, MP
    LIPS, B
    LEMARCHA.T
    BUCHER, HJ
    KOHLER, H
    ACTA ENDOCRINOLOGICA, 1972, 70 (04): : 697 - &
  • [30] SERUM THYROGLOBULIN (TG) LEVEL AS A PREDICTOR OF RELAPSE FOLLOWING TREATMENT OF GRAVES-DISEASE WITH ANTITHYROID DRUGS AND TRIIODOTHYRONINE (T3)
    HARVEY, RD
    HIMSWORTH, RL
    TAYLOR, G
    SCOTTISH MEDICAL JOURNAL, 1987, 32 (06) : 190 - 190
12345